US biotech firm Moderna said Monday its vaccine should remain protective against key coronavirus variants while the unrelenting pandemic led to tightened border restrictions worldwide.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
